Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities.
Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B. Kalhan R, et al. Among authors: ray r. Int J Chron Obstruct Pulmon Dis. 2021 Apr 22;16:1149-1161. doi: 10.2147/COPD.S298032. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33911860 Free PMC article.
Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study.
Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, Mahendran M, Hahn B. Slade D, et al. Among authors: ray r. BMC Pulm Med. 2021 Jul 31;21(1):253. doi: 10.1186/s12890-021-01612-5. BMC Pulm Med. 2021. PMID: 34332555 Free PMC article.
Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study.
Moretz C, Sharpsten L, Bengtson LG, Koep E, Le L, Tong J, Stanford RH, Hahn B, Ray R. Moretz C, et al. Among authors: ray r. Int J Chron Obstruct Pulmon Dis. 2019 Aug 1;14:1721-1737. doi: 10.2147/COPD.S204649. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31534326 Free PMC article.
The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models.
Buikema AR, Brekke L, Anderson A, Koep E, Van Voorhis D, Sharpsten L, Hahn B, Ray R, Stanford RH. Buikema AR, et al. Among authors: ray r. Multidiscip Respir Med. 2018 Oct 11;13:38. doi: 10.1186/s40248-018-0151-6. eCollection 2018. Multidiscip Respir Med. 2018. PMID: 30338068 Free PMC article.
2,268 results